p21CIP1/WAF1 controls proliferation of activated/memory T cells and affects homeostasis and memory T cell responses

Journal of Immunology

Volumn 178, Issue 4, 2007, Pages 2296-2306

  Arias, Cristina F ^a   Ballesteros Tato, André ^a   García, María Isabel ^a   Martín Cabalero, Juan ^b   Flores, Juana M ^c   Martínez A, Carlos ^a   Balomenos, Dimitrios ^a  

^a CENTRO NACIONAL DE BIOTECNOLOGÍA   (Spain)

^b Barcelona Biomedical Research Park   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; OVALBUMIN; PROTEIN P21; T LYMPHOCYTE RECEPTOR; CDKN1A PROTEIN, MOUSE; CYCLIN DEPENDENT KINASE INHIBITOR 1A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL CYCLE; CELL CYCLE REGULATION; CONTROLLED STUDY; FEMALE; HOMEOSTASIS; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MALE; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE ACTIVATION; ANIMAL; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; CELL SURVIVAL; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MOUSE MUTANT;

ANIMALS; APOPTOSIS; AUTOIMMUNITY; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; CYCLIN-DEPENDENT KINASE INHIBITOR P21; HOMEOSTASIS; IMMUNE TOLERANCE; IMMUNOLOGIC MEMORY; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT;

EID: 33846938079     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.178.4.2296     Document Type: Article

References (46)

1. 1 cyclin-dependent kinases. Cell 75: 805-816.
2. Brugarolas, J., C. Chandrasekaran, J. I. Gordon, D. Beach, T. Jacks, and G. J. Hannon. 1995. Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature 377: 552-557.
3. 1 checkpoint control. Cell 82: 675-684.
4. Balomenos, D., J. Martin-Caballero, M. I. Garcia, I. Prieto, J. M. Flores, M. Serrano, and A. C. Martinez. 2000. The cell cycle inhibitor p21 controls T-cell proliferation and sex-linked lupus development. Nat. Med. 6: 171-176.
5. Nguyen, C., N. Limaye, and E. K. Wakeland. 2002. Susceptibility genes in the pathogenesis of murine lupus. Arthritis Res. 4(Suppl. 3): S255-S263.
6. Bygrave, A. E., K. L. Rose, J. Cortes-Hernandez, J. Warren, R. J. Rigby, H. T. Cook, M. J. Walport, T. J. Vyse, and M. Botto. 2004. Spontaneous autoimmunity in 129 and C57BL/6 mice: implications for autoimmunity described in gene-targeted mice. PLoS Biol. 2: e243.
7. Santiago-Raber, M. L., B. R. Lawson, W. Dummer, M. Barnhouse, S. Koundouris, C. B. Wilson, D. H. Kono, and A. N. Theofilopoulos. 2001. Role of cyclin kinase inhibitor p21 in systemic autoimmunity. J. Immunol. 167: 4067-4074.
8. Salvador, J. M., M. C. Hollander, A. T. Nguyen, J. B. Kopp, L. Barisoni, J. K. Moore, J. D. Ashwell, and A. J. Fornace, Jr. 2002. Mice lacking the p53-effector gene Gadd45a develop a lupus-like syndrome. Immunity 16: 499-508.
9. Merino, R., T. Shibata, S. De Kossodo, and S. Izui. 1989. Differential effect of the autoimmune Yaa and lpr genes on the acceleration of lupus-like syndrome in MRL/MpJ mice. Eur. J. Immunol. 19: 2131-2137.
10. WAF-1/Cip1 does not induce systemic autoimmunity in female BXSB mice. J. Immunol. 168: 5928-5932.
11. Balomenos, D., C. Carvalho-Pinto, and A. C. Martinez. 2002. Still waiting for the end: the promise of genomics and proteomics for autoimmune diseases. EMBO Rep. 3: 104-107.
12. Wandstrat, A., and E. Wakeland. 2001. The genetics of complex autoimmune diseases: non-MHC susceptibility genes. Nat. Immunol. 2: 802-809.
13. WAF-1/CIP-1 promotes apoptosis of activated/memory T cells and inhibits spontaneous systemic autoimmunity. J. Exp. Med. 199: 547-557.
14. WAF1/CIP1l ameliorates murine lupus. J. Immunol. 175: 6959-6967.
15. Swain, S. L. 2003. Regulation of the generation and maintenance of T-cell memory: a direct, default pathway from effectors to memory cells. Microbes Infect. 5: 213-219.
16. Moulton, V. R., and D. L. Farber. 2006. Committed to memory: lineage choices for activated T cells. Trends Immunol. 27: 261-267.
17. Freitas, A. A., and B. Rocha. 2000. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18: 83-111.
18. Grossman, Z., and W. E. Paul. 2000. Self-tolerance: context dependent tuning of T cell antigen recognition. Semin. Immunol. 12: 197-203.
19. Murga, M., O. Fernandez-Capetillo, S. J. Field, B. Moreno, L. R. Borlado, Y. Fujiwara, D. Balomenos, A. Vicario, A. C. Carrera, S. H. Orkin, et al. 2001. Mutation of E2F2 in mice causes enhanced T lymphocyte proliferation, leading to the development of autoimmunity. Immunity 15: 959-970.
20. Balomenos, D., and A. C. Martinez. 2000. Cell-cycle regulation in immunity, tolerance and autoimmunity. Immunol. Today 21: 551-555.
21. Carvalho-Pinto, C., M. I. Garcia, L. Gomez, A. Ballesteros, A. Zaballos, J. M. Flores, M. Mellado, J. M. Rodriguez-Frade, D. Balomenos, and A. C. Martinez. 2004. Leukocyte attraction through the CCR5 receptor controls progress from insulitis to diabetes in non-obese diabetic mice. Eur. J. Immunol. 34: 548-557.
22. King, C., A. Ilic, K. Koelsch, and N. Sarvetnick. 2004. Homeostatic expansion of T cells during immune insufficiency generates autoimmunity. Cell 117: 265-277.
23. Gartel, A. L., and A. L. Tyner. 2002. The role of the cyclin-dependent kinase inhibitor p21 in apoptosis. Mol. Cancer Ther. 1: 639-649.
24. WAF1 and IAP gene family ILP. Oncogene 17: 931-939.
25. cip-1/WAF-1, which promotes apoptosis. J. Immunol. 164: 4032-4036.
26. waf1/cip1 transgene on radiation induced apoptosis in T cells. Oncogene 18: 3652-3658.
27. Kip1. J. Immunol. 165: 6270-6277.
28. Khanna, A. K., and J. D. Hosenpud. 2000. In vitro and in vivo transfection of p21 gene enhances cyclosporin A-mediated inhibition of lymphocyte proliferation. J. Immunol. 165: 1882-1888.
29. Khanna, A. K., M. Plummer, V. Nilakantan, and G. M. Pieper. 2005. Recombinant p21 protein inhibits lymphocyte proliferation and transcription factors. J. Immunol. 174: 7610-7617.
30. Witmer, P. D., K. F. Doheny, M. K. Adams, C. D. Boehm, J. S. Dizon, J. L. Goldstein, T. M. Templeton, A. M. Wheaton, P. N. Dong, E. W. Pugh, et al. 2003. The development of a highly informative mouse simple sequence length polymorphism (SSLP) marker set and construction of a mouse family tree using parsimony analysis. Genome Res. 13: 485-491.
31. Carvalho-Pinto, C. E., M. I. Garcia, M. Mellado, J. M. Rodriguez-Frade, J. Martin-Caballero, J. Flores, A. C. Martinez, and D. Balomenos. 2002. Autocrine production of IFN-γ by macrophages controls their recruitment to kidney and the development of glomerulonephritis in MRL/lpr mice. J. Immunol. 169: 1058-1067.
32. + T lymphocytes. J. Immunol. 174: 2481-2484.
33. Slee, E. A., H. Zhu, S. C. Chow, M. MacFarlane, D. W. Nicholson, and G. M. Cohen. 1996. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 315: 21-24.
34. 1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann. Rheum. Dis. 62: 341-346.
35. McMurray, R. W. 2001. Estrogen, prolactin, and autoimmunity: actions and interactions. Int. Immunopharmacol. 1: 995-1008.
36. Mitchell, D. A., M. C. Pickering, J. Warren, L. Fossati-Jimack, J. Cortes-Hernandez, H. T. Cook, M. Botto, and M. J. Walport. 2002. C1q deficiency and autoimmunity: the effects of genetic background on disease expression. J. Immunol. 168: 2538-2543.
37. Cortes-Hernandez, J., L. Fossati-Jimack, F. Petty, M. Loos, S. Izui, M. J. Walport, H. T. Cook, and M. Botto. 2004. Restoration of C1q levels by bone marrow transplantation attenuates autoimmune disease associated with C1q deficiency in mice. Eur. J. Immunol. 34: 3713-3722.
38. Vidal, S., D. H. Kono, and A. N. Theofilopoulos. 1998. Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice. J. Clin. Invest. 101: 696-702.
39. Abbas, A. K. 2003. The control of T cell activation vs. tolerance. Autoimmun. Rev. 2: 115-118.
40. + B cells to produce lupus autoantibodies in vivo. Eur. J. Immunol. 25: 3412-3417.
41. Izui, S., R. Merino, L. Fossati, and M. Iwamoto. 1994. The role of the Yaa gene in lupus syndrome. Int. Rev. Immunol. 11: 211-230.
42. Moulton, V. R., N. D. Bushar, D. B. Leeser, D. S. Patke, and D. L. Farber. 2006. Divergent generation of heterogeneous memory CD4 T cells. J. Immunol. 177: 869-876.
43. + T cell effectors can become memory cells with high efficiency and without further division. Nat. Immunol. 2: 705-710.
44. Ben-Porath, I., and R. A. Weinberg. 2004. When cells get stressed: an integrative view of cellular senescence. J. Clin. Invest. 113: 8-13.
45. + T-cell differentiation in the context of infection. Immunol. Rev. 211: 197-202.
46. Woo, M., R. Hakem, C. Furlonger, A. Hakera, G. S. Duncan, T. Sasaki, D. Bouchard, L. Lu, G. E. Wu, C. J. Paige, and T. W. Mak. 2003. Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificity. Nat. Immunol. 4: 1016-1022.